Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Upcoming)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications
George A. Calin, Carlo M. Croce
George A. Calin, Carlo M. Croce
Published August 1, 2007
Citation Information: J Clin Invest. 2007;117(8):2059-2066. https://doi.org/10.1172/JCI32577.
View: Text | PDF
Review Series

Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications

  • Text
  • PDF
Abstract

There is widespread aberrant expression of mature and/or precursor microRNAs in cancer cells, as microRNAs are deregulated consequent to chromosomal alterations and other genomic abnormalities. The identification of such abnormalities has a clear diagnostic and prognostic significance, and there are ever increasing examples of links between certain human cancers and modifications at microRNA loci.

Authors

George A. Calin, Carlo M. Croce

×

Figure 1

miRNA involvement in cancer initiation and progression.

Options: View larger image (or click on image) Download as PowerPoint
miRNA involvement in cancer initiation and progression.
Alterations in m...
Alterations in miRNA genes play a critical role in the pathophysiology of many, perhaps all, human cancers. Loss or amplification of miRNA genes has been reported in a variety of cancers, and altered patterns of miRNA expression may affect cell cycle and survival programs. Downregulation of suppressor miRNA is accompanied by the hyperexpression of the oncogenic PCG targets (marked in blue), while overexpression of oncogenic miRNA is followed by downregulation of suppressor PCG targets (marked in red). The two paradigms presented in this Review, miR-15a/miR-16-1 cluster and miR-21, are shown in correlation with their main identified targets.

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts